1. Home
  2. CSV vs KROS Comparison

CSV vs KROS Comparison

Compare CSV & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carriage Services Inc.

CSV

Carriage Services Inc.

HOLD

Current Price

$43.88

Market Cap

659.6M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$20.08

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSV
KROS
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.6M
655.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CSV
KROS
Price
$43.88
$20.08
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$59.00
$22.20
AVG Volume (30 Days)
66.7K
971.2K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
1.03%
N/A
EPS Growth
38.46
N/A
EPS
3.09
1.57
Revenue
$409,658,000.00
$246,718,000.00
Revenue This Year
$3.81
$6,876.34
Revenue Next Year
$3.37
N/A
P/E Ratio
$14.12
$12.78
Revenue Growth
1.07
37798.31
52 Week Low
$35.51
$9.12
52 Week High
$49.41
$22.55

Technical Indicators

Market Signals
Indicator
CSV
KROS
Relative Strength Index (RSI) 56.64 57.16
Support Level $43.01 $20.73
Resistance Level $44.45 $21.75
Average True Range (ATR) 0.95 1.06
MACD 0.23 -0.03
Stochastic Oscillator 71.98 57.76

Price Performance

Historical Comparison
CSV
KROS

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: